Tolerability Study of Xerecept® in Pediatric Patients

Clinical trial NCT01369121 · TERMINATED

Trial details

NCT number: NCT01369121
Sponsor: Celtic Pharma Development Services
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain Edema Brain Tumor

Start date: 2010-06-01
Primary completion: 2012-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.